202 related articles for article (PubMed ID: 8426080)
1. Generation of plasmin during acute attacks of hereditary angioedema.
Cugno M; Hack CE; de Boer JP; Eerenberg AJ; Agostoni A; Cicardi M
J Lab Clin Med; 1993 Jan; 121(1):38-43. PubMed ID: 8426080
[TBL] [Abstract][Full Text] [Related]
2. Studies of the mechanisms of bradykinin generation in hereditary angioedema plasma.
Joseph K; Tuscano TB; Kaplan AP
Ann Allergy Asthma Immunol; 2008 Sep; 101(3):279-86. PubMed ID: 18814451
[TBL] [Abstract][Full Text] [Related]
3. Administration of gamma interferon in human subjects decreases plasminogen activation and fibrinolysis without influencing C1 inhibitor.
Gluszko P; Undas A; Amenta S; Szczeklik A; Schmaier AH
J Lab Clin Med; 1994 Feb; 123(2):232-40. PubMed ID: 8301199
[TBL] [Abstract][Full Text] [Related]
4. Prekallikrein activation and high-molecular-weight kininogen consumption in hereditary angioedema.
Schapira M; Silver LD; Scott CF; Schmaier AH; Prograis LJ; Curd JG; Colman RW
N Engl J Med; 1983 May; 308(18):1050-3. PubMed ID: 6601240
[TBL] [Abstract][Full Text] [Related]
5. Treatment of episodes of hereditary angioedema with C1 inhibitor: serial assessment of observed abnormalities of the plasma bradykinin-forming pathway and fibrinolysis.
Joseph K; Tholanikunnel TE; Kaplan AP
Ann Allergy Asthma Immunol; 2010 Jan; 104(1):50-4. PubMed ID: 20143645
[TBL] [Abstract][Full Text] [Related]
6. Plasma levels of C1- inhibitor complexes and cleaved C1- inhibitor in patients with hereditary angioneurotic edema.
Cugno M; Nuijens J; Hack E; Eerenberg A; Frangi D; Agostoni A; Cicardi M
J Clin Invest; 1990 Apr; 85(4):1215-20. PubMed ID: 2318974
[TBL] [Abstract][Full Text] [Related]
7. Activation of the contact system and fibrinolysis in autoimmune acquired angioedema: a rationale for prophylactic use of tranexamic acid.
Cugno M; Cicardi M; Agostoni A
J Allergy Clin Immunol; 1994 May; 93(5):870-6. PubMed ID: 8182230
[TBL] [Abstract][Full Text] [Related]
8. Activation of factor XII and cleavage of high molecular weight kininogen during acute attacks in hereditary and acquired C1-inhibitor deficiencies.
Cugno M; Cicardi M; Coppola R; Agostoni A
Immunopharmacology; 1996 Jun; 33(1-3):361-4. PubMed ID: 8856187
[TBL] [Abstract][Full Text] [Related]
9. Fibrinolysis in health and disease: severe abnormalities in systemic lupus erythematosus.
Glas-Greenwalt P; Kant KS; Allen C; Pollak VE
J Lab Clin Med; 1984 Dec; 104(6):962-76. PubMed ID: 6239000
[TBL] [Abstract][Full Text] [Related]
10. Hereditary angioedema with normal C1 inhibitor: clinical symptoms and course.
Bork K; Gül D; Hardt J; Dewald G
Am J Med; 2007 Nov; 120(11):987-92. PubMed ID: 17976427
[TBL] [Abstract][Full Text] [Related]
11. Immunoblotting of plasma in a pregnant patient with hereditary angioedema.
Chhibber G; Cohen A; Lane S; Farber A; Meloni FJ; Schmaier AH
J Lab Clin Med; 1990 Jan; 115(1):112-21. PubMed ID: 1688910
[TBL] [Abstract][Full Text] [Related]
12. Elevated plasmin-alpha 2-antiplasmin complex levels in hereditary angioedema: evidence for the in vivo efficiency of the intrinsic fibrinolytic system.
Nilsson T; Bäck O
Thromb Res; 1985 Dec; 40(6):817-21. PubMed ID: 2935973
[TBL] [Abstract][Full Text] [Related]
13. C1-inhibitor (C1-INH) autoantibodies in hereditary angioedema. Strong correlation with the severity of disease in C1-INH concentrate naïve patients.
Varga L; Széplaki G; Visy B; Füst G; Harmat G; Miklós K; Németh J; Cervenak L; Karádi I; Farkas H
Mol Immunol; 2007 Feb; 44(6):1454-60. PubMed ID: 16750855
[TBL] [Abstract][Full Text] [Related]
14. Bradykinin in the ascitic fluid of patients with liver cirrhosis.
Cugno M; Salerno F; Nussberger J; Bottasso B; Lorenzano E; Agostoni A
Clin Sci (Lond); 2001 Dec; 101(6):651-7. PubMed ID: 11724653
[TBL] [Abstract][Full Text] [Related]
15. Kallikrein-kinin system and fibrinolysis in hereditary angioedema due to factor XII gene mutation Thr309Lys.
Bork K; Kleist R; Hardt J; Witzke G
Blood Coagul Fibrinolysis; 2009 Jul; 20(5):325-32. PubMed ID: 19474702
[TBL] [Abstract][Full Text] [Related]
16. Cleavage of the second component of complement by plasma proteases: implications in hereditary C1-inhibitor deficiency.
Smith MA; Kerr MA
Immunology; 1985 Nov; 56(3):561-70. PubMed ID: 2934317
[TBL] [Abstract][Full Text] [Related]
17. Detection and quantitation of cleaved and uncleaved high molecular weight kininogen in plasma by ligand blotting with radiolabeled plasma prekallikrein or factor XI.
Lämmle B; Zuraw BL; Heeb MJ; Schwarz HP; Berrettini M; Curd JG; Griffin JH
Thromb Haemost; 1988 Apr; 59(2):151-61. PubMed ID: 3388291
[TBL] [Abstract][Full Text] [Related]
18. Hereditary angioedema: a decade of human C1-inhibitor concentrate therapy.
Farkas H; Jakab L; Temesszentandrási G; Visy B; Harmat G; Füst G; Széplaki G; Fekete B; Karádi I; Varga L
J Allergy Clin Immunol; 2007 Oct; 120(4):941-7. PubMed ID: 17761272
[TBL] [Abstract][Full Text] [Related]
19. Complement, coagulation and fibrinolytic parameters in hereditary angioedema (HAE).
Cullmann W; Kövary PM; Müller N; Dick W
Clin Exp Immunol; 1982 Sep; 49(3):618-22. PubMed ID: 7172497
[TBL] [Abstract][Full Text] [Related]
20. The pathophysiology of hereditary angioedema.
Davis AE
Clin Immunol; 2005 Jan; 114(1):3-9. PubMed ID: 15596403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
